MarcERothenbergMD
Allergy & Immunology • Cincinnati, OHPediatric Asthma & Allergic Conditions
Professor, Pediatrics, University of Cincinnati College of Medicine
Dr. Rothenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3333 Burnet Ave
Ml 2000
Cincinnati, OH 45229Phone+1 513-636-6771Fax+1 513-636-4615- Is this information wrong?
Education & Training
Children's HospitalFellowship, Allergy and Immunology, 1992 - 1994- Children's Hospital/Boston Medical CenterResidency, Pediatrics, 1990 - 1992
Harvard Medical SchoolClass of 1990
Certifications & Licensure
OH State Medical License 1997 - 2026
MA State Medical License 1992 - 1997- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2000
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Clinical Trials
- Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome Start of enrollment: 2001 Dec 01
- A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders Start of enrollment: 2002 Oct 01
- Data Bank for Eosinophilic Disorders Start of enrollment: 2001 May 01
- Join now to see all
Publications & Presentations
PubMed
- Common and Disparate Clinical Presentations and Mechanisms in Different Eosinophilic Gastrointestinal Diseases.Tetsuo Shoda, Richard J Taylor, Naoya Sakai, Marc E Rothenberg> ;The Journal of Allergy and Clinical Immunology. 2024 Mar 28
- 1 citationsMachine learning-based identification and characterization of mast cells in eosinophilic esophagitis.Simin Zhang, Julie M Caldwell, Mark Rochman, Margaret H Collins, Marc E Rothenberg> ;The Journal of Allergy and Clinical Immunology. 2024 Feb 22
- Impact of climate change on immune responses and barrier defense.Skevaki, C., Nadeau, K., Alahmad, B., Mmbaga, B., Masenga, G., Sampath, V., Haahtela, T., Renz, H., Rothenberg, M., Christiani, D.> ;The Journal of Allergy and Clinical Immunology. 2024 Feb 2
- Join now to see all
Journal Articles
- Genetic Variants at the 16p13 Locus Confer Risk for Eosinophilic EsophagitisRobert P Kimberly, Marc E Rothenberg, Patrick M Gaffney, Hugh A Sampson, J Pablo Abonia, Mirna Chehade, Philip E Putnam, Brian P Vickery, Glenn T Furuta, John B Harley, Nature
Press Mentions
Eosinophilic Esophagitis Diet EffectivenessMay 22nd, 2023- Results of First Multi-Site Randomized Trial Comparing the Two Diets — ScienceDailyMarch 1st, 2023
- Avoiding Just This Dietary Trigger Helps Resolve Eosinophilic EsophagitisMarch 1st, 2023
- Join now to see all
Grant Support
- Regulation Of Gastrointestinal EosinophilsNational Institute Of Allergy And Infectious Diseases2010–2012
- Role Of Desmoglein-1 In Eosinophilic EsophagitisNational Institute Of Allergy And Infectious Diseases2011
- IL-13 And Eosinophilic EsophagitisNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- IL-13 Associated Eosinophil Lung ResponsesNational Institute Of Allergy And Infectious Diseases2010–2011
- Eosinophilic Esophagitis And Food AllergyNational Institute Of Allergy And Infectious Diseases2010–2011
- Epithelial-Derived Eotaxin 3 In Eosinophilic EsophagitisNational Institute Of Allergy And Infectious Diseases2010
- A Multi-Center Clinical Trial Of 1760 MCG Of Daily Swallowed Fluticasone Vs. PlacNational Institute Of Allergy And Infectious Diseases2010
- IL-13 Associated Eosinophil Lung ResponsesNational Institute Of Allergy And Infectious Diseases2009
- A Multi-Center Clinical Trial Of 1760 MCG Of Daily Swallowed Fluticasone Vs. PlacNational Institute Of Allergy And Infectious Diseases2009
- IL-13 And Eosinophilic EsophagitisNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
- Epithelial-Derived Eotaxin 3 In Eosinophilic EsophagitisNational Institute Of Allergy And Infectious Diseases2006–2009
- Clinical Trial: Effect Of Intravenous Anti-Il5 (MEPOLIZUMAB) In HypereosinophiliNational Center For Research Resources2008
- Regulation Of Gastrointestinal EosinophilisNational Institute Of Allergy And Infectious Diseases2004–2008
- Role Of Eotaxins And CCR3 In IL-13 Induced AsthmaNational Heart, Lung, And Blood Institute2004–2008
- Core--Breeding And GenotypingNational Heart, Lung, And Blood Institute2004–2008
- Effect Of Intravenous Anti-Il5 (MEPOLIZUMAB) In Hypereosinophilic SyndromesNational Center For Research Resources2005–2007
- Eosinophil, Chemokine And IL-13 Cooperativity In AsthmaNational Institute Of Allergy And Infectious Diseases2004–2007
- Role Of Arginase In Allergic Airway InflammationNational Institute Of Allergy And Infectious Diseases2003–2007
- Anti-Il 5 For HypereosinophiliaFood And Drug Administration2005
- IV Anti-Il5 (MEPOLIZUMAB) In Hypereosinophilic SyndromesNational Center For Research Resources2004
- Regulation Of Gastrointestinal EosinophilsNational Institute Of Allergy And Infectious Diseases1999–2002
- Mechanisms Of Eosinophilia In Experimental AsthmaNational Institute Of Allergy And Infectious Diseases1998–2002
Professional Memberships
- Fellow
Hospital Affiliations
Cincinnati Children's Hospital Medical CenterCincinnati, Ohio
Christ HospitalCincinnati, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
